Aurélie De Bruycker

2.1k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Aurélie De Bruycker is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Electrical and Electronic Engineering. According to data from OpenAlex, Aurélie De Bruycker has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Electrical and Electronic Engineering. Recurrent topics in Aurélie De Bruycker's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Aurélie De Bruycker is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Aurélie De Bruycker collaborates with scholars based in Belgium, United States and Switzerland. Aurélie De Bruycker's co-authors include Piet Ost, Karel Decaestecker, Valérie Fonteyne, Nicolaas Lumen, Louke Delrue, Kathia De Man, Bieke Lambert, Ignace Billiet, Gert De Meerleer and Steven Joniau and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Aurélie De Bruycker

18 papers receiving 1.2k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

2017 831 citations Piet Ost, Dries Reynders et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aurélie De Bruycker Belgium	9	1.0k	494	217	197	165	20	1.2k
Kathia De Man Belgium	14	1.1k 1.1×	568 1.1×	202 0.9×	249 1.3×	162 1.0×	37	1.3k
Friedl Vanhaverbeke Belgium	4	842 0.8×	417 0.8×	185 0.9×	177 0.9×	136 0.8×	6	1.0k
Dries Reynders Belgium	11	854 0.8×	410 0.8×	188 0.9×	285 1.4×	139 0.8×	22	1.2k
Cristian Udovicich Australia	11	934 0.9×	447 0.9×	103 0.5×	143 0.7×	122 0.7×	35	1.1k
F. Casamassima Italy	14	729 0.7×	436 0.9×	513 2.4×	190 1.0×	124 0.8×	41	1.1k
Maurits Wondergem Netherlands	16	729 0.7×	576 1.2×	126 0.6×	175 0.9×	99 0.6×	63	1.1k
Christoph Henkenberens Germany	19	776 0.8×	562 1.1×	83 0.4×	183 0.9×	146 0.9×	50	1.0k
Kilian Schiller Germany	13	825 0.8×	573 1.2×	119 0.5×	167 0.8×	112 0.7×	35	969
Stephanie Kroeze Switzerland	18	658 0.6×	231 0.5×	89 0.4×	255 1.3×	91 0.6×	43	930
Alessio Bruni Italy	15	463 0.5×	243 0.5×	150 0.7×	187 0.9×	114 0.7×	65	705

Countries citing papers authored by Aurélie De Bruycker

Since Specialization

Citations

This map shows the geographic impact of Aurélie De Bruycker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie De Bruycker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie De Bruycker more than expected).

Fields of papers citing papers by Aurélie De Bruycker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie De Bruycker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie De Bruycker. The network helps show where Aurélie De Bruycker may publish in the future.

Co-authorship network of co-authors of Aurélie De Bruycker

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie De Bruycker. A scholar is included among the top collaborators of Aurélie De Bruycker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie De Bruycker. Aurélie De Bruycker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andrews, Jack R., Aurélie De Bruycker, Ryan Phillips, et al.. (2025). PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts. Clinical Cancer Research. 31(6). 1142–1149. 5 indexed citations

Bruycker, Aurélie De, Wilfried De Neve, Jean‐François Daisne, et al.. (2024). Disease Control and Late Toxicity in Adaptive Dose Painting by Numbers Versus Nonadaptive Radiation Therapy for Head and Neck Cancer: A Randomized Controlled Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). 516–527. 2 indexed citations

Bruycker, Aurélie De, et al.. (2024). Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights. Lung Cancer. 193. 107848–107848. 2 indexed citations

Sundahl, Nora, Aurélie De Bruycker, Valérie Fonteyne, et al.. (2023). Microbiome and metabolome dynamics during radiotherapy for prostate cancer. Radiotherapy and Oncology. 189. 109950–109950. 5 indexed citations

Duprez, Fréderic, et al.. (2021). P-15 Implementation of cancer nurse-led consultations for patients with head and neck cancer through the care pathway: a renewed care. Oral Oncology. 118. 6–6. 1 indexed citations

Bruycker, Aurélie De, Phuoc T. Tran, Ariel H. Achtman, & Piet Ost. (2020). Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries. World Journal of Urology. 39(2). 317–326. 17 indexed citations

Ost, Piet, Dries Reynders, Karel Decaestecker, et al.. (2020). Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.. Journal of Clinical Oncology. 38(6_suppl). 10–10. 91 indexed citations

Ost, Piet, Dries Reynders, Nicolaas Lumen, et al.. (2020). OC-0370: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer (STOMP). Radiotherapy and Oncology. 152. S200–S201. 1 indexed citations

Bleser, Elise De, Ruben Willems, Karel Decaestecker, et al.. (2020). A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer. Cancers. 12(1). 132–132. 12 indexed citations

10.

Steuber, Thomas, Cordula A. Jilg, Pierre Tennstedt, et al.. (2018). Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. European Urology Focus. 5(6). 1007–1013. 80 indexed citations

11.

Dhondt, Bert, Elise De Bleser, Tom Claeys, et al.. (2018). Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time. World Journal of Urology. 37(12). 2557–2564. 25 indexed citations

12.

Bruycker, Aurélie De, Elise De Bleser, Karel Decaestecker, et al.. (2018). Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. European Urology. 75(5). 826–833. 37 indexed citations

13.

Ost, Piet, Dries Reynders, Nicolaas Lumen, et al.. (2018). SP-0375: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence. Radiotherapy and Oncology. 127. S191–S192.

14.

Ost, Piet, Dries Reynders, Karel Decaestecker, et al.. (2017). Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial. Journal of Clinical Oncology. 36(5). 446–453. 831 indexed citations breakdown →

15.

Huysse, Wouter, Frédéric Lecouvet, Paolo Castellucci, et al.. (2017). Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients. Diagnostics. 7(4). 56–56. 8 indexed citations

16.

Bruycker, Aurélie De, Bieke Lambert, Tom Claeys, et al.. (2017). Prevalence and prognosis of low‐volume, oligorecurrent, hormone‐sensitive prostate cancer amenable to lesion ablative therapy. British Journal of Urology. 120(6). 815–821. 45 indexed citations

17.

Zhou, Mengjie, et al.. (1993). Modified spice modelling of DC characteristics for high-voltage DMOS transistors. Electronics Letters. 29(1). 126–127. 1 indexed citations

18.

Zhou, Mengjie, Herbert De Smet, Aurélie De Bruycker, & André Van Calster. (1993). A 2-D boundary element method approach to the simulation of DMOS transistors. IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 12(6). 810–816. 2 indexed citations

19.

Bruycker, Aurélie De, Mengjie Zhou, André Van Calster, & J. Witters. (1993). Improved negative dynamic resistance model for high voltage MOSFETs. Electronics Letters. 29(2). 212–213. 3 indexed citations

20.

Zhou, Mengjie, et al.. (1992). Breakdown walkout and its reduction in high-voltage pLDMOS transistors on thin epitaxial layer. Electronics Letters. 28(16). 1537–1538. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact